跳至主要内容
临床试验/IRCT20220417054557N2
IRCT20220417054557N2招募中3 期

Investigation the effect of Inositol in patients with Primary Sclerosing Cholangitis

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • cholestatic liver disease for at least 6 months
  • serum alkaline phosphatase levels 1.5 times the normal upper limit

排除标准

  • co-existing liver diseases such as alcoholic liver disease and NAFLD, autoimmune hepatitis, chronic B or C hepatitis, PBC, hemochromatosis, Wilson's disease, congenital biliary disease, and cholangiocarcinoma

研究者

相似试验

The effect of inositol on the improvement of primary... | 临床试验